The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Cyclosporine before PCI in Patients with Acute Myocardial Infarction
Open accessAbstract
BACKGROUND: Experimental and clinical evidence suggests that cyclosporine may attenuate reperfusion injury and reduce myocardial infarct size. We aimed to test whether cyclosporine would improve clinical outcomes and prevent adverse left ventricular remodeling. METHODS: In a multicenter, double-blind, randomized trial, we assigned 970 patients with an acute anterior ST-segment elevation myocardial infarction (STEMI) who were undergoing percutaneous coronary intervention (PCI) within 12 hours after symptom onset and who had complete occlusion of the culprit coronary artery to receive a bolus injection of cyclosporine (administered intravenously at a dose of 2.5 mg per kilogram of body weight) or matching placebo before coronary recanalization. The primary outcome was a composite of death from any cause, worsening of heart failure during the initial hospitalization, rehospitalization for heart failure, or adverse left ventricular remodeling at 1 year. Adverse left ventricular remodeling was defined as an increase of 15% or more in the left ventricular end-diastolic volume. RESULTS: A total of 395 patients in the cyclosporine group and 396 in the placebo group received the assigned study drug and had data that could be evaluated for the primary outcome at 1 year. The rate of the primary outcome was 59.0% in the cyclosporine group and 58.1% in the control group (odds ratio, 1.04; 95% confidence interval [CI], 0.78 to 1.39; P=0.77). Cyclosporine did not reduce the incidence of the separate clinical components of the primary outcome or other events, including recurrent infarction, unstable angina, and stroke. No significant difference in the safety profile was observed between the two treatment groups. CONCLUSIONS: In patients with anterior STEMI who had been referred for primary PCI, intravenous cyclosporine did not result in better clinical outcomes than those with placebo and did not prevent adverse left ventricular remodeling at 1 year. (Funded by the French Ministry of Health and NeuroVive Pharmaceutical; CIRCUS ClinicalTrials.gov number, NCT01502774; EudraCT number, 2009-013713-99.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“with relatively deceiving results (despite multiple clinical trials, no drug based on this concept has ever been approved for use in humans by regulatory agencies) [387].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [387]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Authors Task Force Members, Steg, P. G., James, S. K., Atar, D., Badano, L. P., Lundqvist, C. B., Borger, M. A., Mario, C. D., Dickstein, K., Ducrocq, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs215 · Cited by 6,890
Self-citationYellon, D. M., & Hausenloy, D. J. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071667 · Cited by 3,797
Baines, C. P., Kaiser, R. A., Purcell, N. H., Blair, N. S., Osinska, H., Hambleton, M. A., Brunskill, E. W., Sayen, M. R., Gottlieb, R. A., Dorn, G. W., et al. (2005) · Nature · doi:10.1038/nature03434 · Cited by 2,280
Nakagawa, T., Shimizu, S., Watanabe, T., Yamaguchi, O., Otsu, K., Yamagata, H., Inohara, H., Kubo, T., & Tsujimoto, Y. (2005) · Nature · doi:10.1038/nature03317 · Cited by 1,635
Effect of Cyclosporine on Reperfusion Injury in Acute Myocardial Infarction
Piot, C. A., Croisille, P., Staat, P., Thibault, H., Rioufol, G., Mewton, N., Belghiti, R. E., Cung, T. T., Bonnefoy‐Cudraz, E., Angoulvant, D., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa071142 · Cited by 1,339
Self-citationEvolving Therapies for Myocardial Ischemia/Reperfusion Injury
Ibáñez, B., Heusch, G., Ovize, M., & de Werf, F. V. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.02.032 · Cited by 1,014
Self-citationMitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion
Griffiths, E. J., & Halestrap, A. P. (1995) · Biochemical Journal · doi:10.1042/bj3070093 · Cited by 838
Randomized Trial of Primary PCI with or without Routine Manual Thrombectomy
Jolly, S. S., Cairns, J. A., Yusuf, S., Meeks, B., Pogue, J. M., Rokoss, M. J., Kedev, S. A., Thabane, L., Stankovic, G. R., Moreno, R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1415098 · Cited by 665
Self-citationSteg, P. G., Greenlaw, N., Tardif, J., Tendera, M., Ford, I., Kääb, S., Abergel, H., Fox, K. M., Ferrari, R., & on behalf of the CLARIFY Registry Investigators (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs289 · Cited by 653
Self-citationHausenloy, D. J. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00455-8 · Cited by 585
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 714
Li, G., & Huang, X. (2020) · Human & Experimental Toxicology · doi:10.1177/0960327120950006 · Cited by 5
RetractedImpact of periprocedural morphine use on mortality in STEMI patients treated with primary PCI
Domokos, D., Szabó, A., Bánhegyi, G., Major, L., Kiss, R. G., Becker, D. J., Edes, I. F., Ruzsa, Z., Merkely, B. P., & Hizoh, I. (2021) · PLoS ONE · doi:10.1371/journal.pone.0245433 · Cited by 5
Li, H., Wang, T., Feng, Y.-Y., Sun, K., Huang, G., Cao, Y., & Xu, A.-L. (2023) · MedComm · doi:10.1002/mco2.289 · Cited by 4
Ravíngerová, T., Adameová, A., Lonek, L., Farkašová, V., Ferko, M., Andelová, N., Kura, B., Slezák, J., Galatou, E., Lazou, A., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216497 · Cited by 6
Peptidylprolyl Isomerases as In Vivo Carriers for Drugs That Target Various Intracellular Entities
Gałat, A. (2017) · Biomolecules · doi:10.3390/biom7040072 · Cited by 5
Functional cyclophilin D moderates platelet adhesion, but enhances the lytic resistance of fibrin
Varjú, I., Farkas, V. J., Kőhidai, L., Szabó, L. F., Farkas, A. Z., Polgár, L., Chinopoulos, C., & Kolev, K. (2018) · Scientific Reports · doi:10.1038/s41598-018-23725-4 · Cited by 5
Cardioprotection for Acute MI in Light of the CONDI2/ERIC-PPCI Trial: New Targets Needed
Giblett, J. P., & Bulluck, H. (2020) · Interventional Cardiology Reviews Research Resources · doi:10.15420/icr.2020.01 · Cited by 5
Al-Kouh, A., Babiker, F. A., & Al‐Bader, M. (2023) · Pharmaceuticals · doi:10.3390/ph16020238 · Cited by 5
Kardioprotektion beim herzchirurgischen Patienten
Stoppe, C., Meybohm, P., Coburn, M., & Goetzenich, A. (2016) · Der Anaesthesist · doi:10.1007/s00101-016-0141-z · Cited by 5
Mitochondrial dysfunction and kidney disease
Dalbhi, S. A., Alqarni, F., Bahatheq, N. M., Alrasheed, R. S., Alkhowaiter, R. A., & Alnughaimshi, A. A. (2019) · Journal of Nephropathology · doi:10.15171/jnp.2019.18 · Cited by 5
Attenuation of ischemia–reperfusion injury by intracoronary chelating agent administration
Han, D., Kang, S., Yoon, C., Youn, T., & Chae, I. (2022) · Scientific Reports · doi:10.1038/s41598-022-05479-2 · Cited by 5
Protecting the Mitochondria in Cardiac Disease
Lazou, A., & Ramachandra, C. J. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158115 · Cited by 5
Selección de temas de actualidad en cardiopatía isquémica y cuidados agudos cardiológicos 2015
Nuñez-Gil, I. J., Martín-Reyes, R., Bardajı́, A., Alonso, J. J., Abu-Assi, E., Vivas, D., Sionís, A., Almendro‐Delia, M., & Lidón, R. M. (2016) · Revista Española de Cardiología · doi:10.1016/j.recesp.2015.12.017 · Cited by 4
Ischemic Heart Disease and Acute Cardiac Care 2015: A Selection of Topical Issues
Nuñez-Gil, I. J., Martín-Reyes, R., Bardajı́, A., Alonso, J. J., Abu-Assi, E., Vivas, D., Sionís, A., Almendro‐Delia, M., & Lidón, R. M. (2016) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2015.12.017 · Cited by 4
Ferroptosis Exists in Ischemia Reperfusion Injury after Cardiac Surgery with Cardiopulmonary Bypass
Zhang, S., Li, J., Wang, J., Chen, X., Shu, G., Feng, D., & Zheng, X. (2024) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-024-01228-6 · Cited by 4
Dysregulation of Mitochondrial Homeostasis in Cardiovascular Diseases
Patil, R., Wang, H., Kazaleh, M., Ailawadi, G., & Salmon, M. (2025) · Pharmaceuticals · doi:10.3390/ph18010112 · Cited by 4
The application of nanomedicines in repairing damage in myocardial infarction
Zheng, S., Chen, D., Zhao, M., & Hu, H. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114388 · Cited by 4
Ischemia–Reperfusion Injury: Molecular Mechanisms and Therapeutic Interventions
An, P., An, Y., Chen, M., Wu, L., & Wang, R. (2026) · MedComm · doi:10.1002/mco2.70822 · Cited by 4
Claeys, M. J., Coussement, P. K., Dubois, P., García‐Dorado, D., Mewton, N., Amaz, C., & Ovize, M. (2019) · American Heart Journal · doi:10.1016/j.ahj.2019.05.010 · Cited by 4
Self-citationZhao, Y., Ling, F., Qin, Y., Xie, W., Qi, W., Nie, Q., Zhang, H., Han, M., Zhao, J., Liu, L., et al. (2024) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-024-04608-w · Cited by 4
Sciuto, K. J., Deng, S. W., Venable, P. W., Warren, M. D., Warren, J. S., & Zaitsev, A. V. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200301 · Cited by 4
Omoto, A. C. M., Gava, F. N., Silva, C. A. A., Silva, H. B., Parente, J. M., da Costa, R. M., de Castro, M. M., Tostes, R. C., Salgado, H. C., & Fazan, R. (2018) · PLoS ONE · doi:10.1371/journal.pone.0209190 · Cited by 4
Sciuto, K. J., Deng, S. W., Moreno, A. P., & Зайцев, А. В. (2019) · PLoS ONE · doi:10.1371/journal.pone.0212076 · Cited by 4
Techiryan, G., Weil, B. R., Young, R. F., & Canty, J. M. (2022) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00373.2022 · Cited by 4
Kaur, K., Singh, N., & Dhawan, R. K. (2019) · Europe PMC (PubMed Central) · doi:10.22038/ijbms.2019.14067 · Cited by 4
Chen, C., Xia, J., Feng, R., Wan, J., Zhou, K., Lin, Q., & Li, D. (2021) · Medicine · doi:10.1097/md.0000000000024944 · Cited by 4
Sung, P., Huang, W., Chao, T.-H., Lee, C., Yang, T., Lin, Y., Chang, R.-Y., Chong, J., Yang, C., Chen, C. J., et al. (2021) · PubMed Central · doi:10.6515/acs.202105_37(3).20201025c · Cited by 4
Past, Present, and Future of Management of Acute Myocardial Infarction
Lee, S. H., Hong, Y. J., Ahn, Y., & Jeong, M. H. (2023) · Journal of Cardiovascular Intervention · doi:10.54912/jci.2022.0023 · Cited by 4
Bonanad, C., González‐Parra, E., Rivera, R., Carrascosa, J. M., Daudén, E., Olveira, A., & Estrada, R. B. (2017) · Actas Dermo-Sifiliográficas · doi:10.1016/j.adengl.2017.08.021 · Cited by 4
Rationale and design of the cyclosporine in Takotsubo syndrome (CIT) trial
Bruns, B., Elsous, N., Burghaus, I., Steyrer, K., Joos, M. C., Krämer, T., Scheffel, M., Blankenberg, S., Eitel, I., Maßberg, S., et al. (2025) · American Heart Journal · doi:10.1016/j.ahj.2025.04.020 · Cited by 3
Solis‐Jiménez, F., Araiza-Garaygordobil, D., Masso-Bueso, J. S., Villalobos-Ordaz, A., Arellano‐Juvera, F., Arredondo-Aragon, F., Melendez-Ramirez, G., Valdez-Ortiz, R., Alday-Ramirez, S. M., Rodriguez-Zanella, H. G., et al. (2025) · European Heart Journal Open · doi:10.1093/ehjopen/oeaf128 · Cited by 3
Wang, Y., Li, Y., Zhou, Y., Zhang, H., Zang, J., Yang, C., Gao, Z., Hou, Y., & Song, M. (2025) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2025.10.002 · Cited by 3
Pyroptosis in acute pancreatitis: from pathogenesis to treatment
Wu, Q., & Ji, Z. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000003932 · Cited by 3
Valinsky, W. C., Ray, R. P., Schaefer, K., Grimm, J. B., Nicolini, C., Lavis, L. D., & Clapham, D. E. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2535298123 · Cited by 3
Liu, D., Lin, R., Bo, T., Hu, J., Cheng, L., Lou, X., Li, M., Li, S., Zhu, Y., Li, N., et al. (2023) · The International Journal of Cardiovascular Imaging · doi:10.1007/s10554-023-02860-8 · Cited by 3
Carulli, E., McGarvey, M., Chabok, M., Panoulas, V., Rosser, G. J., Akhtar, M. M., Smith, R. C., Chandra, N., Al-Hussaini, A., Kabir, T., et al. (2024) · American Heart Journal · doi:10.1016/j.ahj.2024.12.009 · Cited by 3
Infections, infarction, and heart failure: prevention and management
Lüscher, T. F. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv618 · Cited by 3
Lavi, S., & Lavi, R. (2017) · Journal of Thoracic Disease · doi:10.21037/jtd.2017.07.116 · Cited by 3
Cyclophilin D knockout mice do not accumulate succinate during cardiac ischemia
Prag, H. A., Kula‐Alwar, D., Bernardi, P., Lisa, F. D., Murphy, M. P., & Krieg, T. (2022) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2022.09.006 · Cited by 3
Lupu, M., Tudor, D. V., & Filip, G. A. (2022) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2021.09.022 · Cited by 3
Li, L., Niemann, B., Knapp, F., Werner, S., Mühlfeld, C., Schneider, J. P., Jurida, L., Molenda, N., Schmitz, M. L., Yin, X., et al. (2024) · Basic Research in Cardiology · doi:10.1007/s00395-024-01051-3 · Cited by 3
Wu, H., Diao, H., Zhang, F., Jiang, W., Pan, T., & Bian, Y. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.117978 · Cited by 3
Mitochondria for Cardiovascular Therapy: A Deep Dive into Drug Targets and Therapeutic Approaches
Semenzato, M., & Naón, D. (2025) · Current Pharmacology Reports · doi:10.1007/s40495-025-00405-2 · Cited by 3
Bourezg, A., Bochaton, T., Mewton, N., Morel, O., Cayla, G., Rioufol, G., Bonnefoy‐Cudraz, E., Guérin, P., Elbaz, M., Boussaha, I., et al. (2018) · Journal of Cardiology · doi:10.1016/j.jjcc.2018.03.008 · Cited by 3
Self-citationZhao, Y., Chen, W., Yan, X.-Y., Liu, K., Liu, G., & Yang, P. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i32.11955 · Cited by 3
Simon, B. V., Beutner, G., Swartz, M. F., Angona, R. E., Smith, K., Porter, G. A., & Alfieris, G. M. (2022) · Journal of ExtraCorporeal Technology · doi:10.1051/ject/202254203 · Cited by 3
Ko, B.-S., Drakos, S. G., Welt, F. G. P., & Shah, R. U. (2016) · Interventional Cardiology Clinics · doi:10.1016/j.iccl.2016.06.010 · Cited by 3
Ischemic Postconditioning and Milrinone
Steppan, J., Berkowitz, D. E., & Nyhan, D. P. (2018) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2018.01.047 · Cited by 3
Molecular Targets and Novel Therapeutics to Target Oxidative Stress in Cardiovascular Diseases
Dhawan, V., Bakshi, C., & Rather, R. A. (2019) · Springer eBooks · doi:10.1007/978-981-13-8273-4_4 · Cited by 3
de Paula, L. J. C., Uchida, A. H., Rezende, P. C., Soares, P. R., & Scudeler, T. L. (2022) · Current Vascular Pharmacology · doi:10.2174/1570161120666220819163025 · Cited by 3
A Slick Way Volatile Anesthetics Reduce Myocardial Injury
Wagner, N., Gross, E. R., & Patel, H. H. (2016) · Anesthesiology · doi:10.1097/aln.0000000000001047 · Cited by 3
Smith, J., & Goggs, R. A. N. (2018) · Wiley eBooks · doi:10.1002/9781119028994.ch158 · Cited by 3
Clarification Regarding the Lack of Heart Failure Events in the ASSAIL-MI Trial
Buono, M. G. D., Tassell, B. W. V., & Abbate, A. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.04.105 · Cited by 3
Regulation of mitochondrial biogenesis and energy metabolism in the heart
She, P., 莫非, Zhu, P., & Zhong, T. P. (2026) · Chinese Medical Journal · doi:10.1097/cm9.0000000000004011 · Cited by 2
Morciano, G., Pedriali, G., Turrin, G., Algieri, C., Agyapong, E. D., Mantia, D. L., Bernardini, C., Canini, G., Fantinati, A., Colarusso, E. N., et al. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104097 · Cited by 2
Nasoufidou, A., Bantidos, M. G., Kofos, C., Stalikas, N., Mitsis, A., Stachteas, P., Karakasis, P., Fasoula, M., Fyntanidou, B., Kassimis, G., et al. (2026) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2026.2703072 · Cited by 2
Historical account of reperfusion therapy and the development of cardioprotection beyond reperfusion
Heusch, G., Kleinbongard, P., & Gersh, B. J. (2026) · Basic Research in Cardiology · doi:10.1007/s00395-026-01198-1 · Cited by 2
Interventional Cardiology 2015: A Selection of Topical Issues
Hernández, F., Hernández, J. M. D. L. T., Cuevas, J. R. R., del Blanco, B. G., Martínez, J. L. Z., & Trillo, R. (2016) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2015.12.014 · Cited by 2
Selección de temas de actualidad en cardiología intervencionista 2015
Hernández, F., Hernández, J. M. D. L. T., Cuevas, J. R. R., del Blanco, B. G., Martínez, J. L. Z., & Trillo, R. (2016) · Revista Española de Cardiología · doi:10.1016/j.recesp.2015.12.014 · Cited by 2
Lüscher, T. F. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx085 · Cited by 2
Mitochondrial Disruption in Cardiovascular Diseases
Lesnefsky, E. J., Chen, Q., Tandler, B., & Hoppel, C. L. (2018) · Springer eBooks · doi:10.1007/978-3-319-73344-9_12 · Cited by 2
Mitochondrial dyshomeostasis in cardiac aging and related diseases
Wang, J., YuJing, L. I., ZHANG, H., SiQi, C. H. E. N., Wang, Y., & Song, M. (2023) · Scientia Sinica Vitae · doi:10.1360/ssv-2021-0366 · Cited by 2
Vanhaverbeke, M., Veltman, D., Janssens, S. P., & Sinnaeve, P. (2020) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-020-10048-x · Cited by 2
Veno-occlusive unloading of the heart reduces infarct size in experimental ischemia–reperfusion
Hansen, E. S. S., Madsen, T. L., Wood, G., Granfeldt, A., Bøgh, N., Tofig, B. J., Agger, P., Lindhardt, J. L., Poulsen, C. B., Bøtker, H. E., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-84025-y · Cited by 2
REPERFUSION INJURY IN ACUTE PERIOD OF MYOCARDIAL INFARCTION – WAYS OF PREVENTION AND CORRECTION
Vytrykhovskyi, A. I., & Fedorchenko, M. V. (2022) · Wiadomości Lekarskie · doi:10.36740/wlek202210137 · Cited by 2
Chang, S., Chu, C., Cheng, C.-S., Pan, K., Lin, Y., Chung, C., & Lin, M. (2023) · PubMed Central · doi:10.6515/acs.202301_39(1).20220623a · Cited by 2
Cohen, M. V., & Downey, J. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105477 · Cited by 2
Ojeda, F. B., Vargas, C. M., Almeida, J. L., Gómez, M. M. I., Jiménez, A., Jiménez, C. R., Flecha, A. S., Santana, M. B., & Bowden, G. Y. (2024) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.31267 · Cited by 2
Saludas, L., Garbayo, E., Abizanda, G., Dormont, F., Santamaría, E., Prósper, F., Couvreur, P., & Blanco‐Prieto, M. J. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114369 · Cited by 2
Lack of benefit of cyclosporine to attenuate reperfusion injury after PCI
Lim, G. B. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.141 · Cited by 2
Cyclosporine for Reperfusion Injury After Cardiac Arrest
Becker, L. B., & Berger, P. B. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.1822 · Cited by 2
McGarvey, M., Ali, O., Iqbal, M. B., Ilsley, C. D. J., Wong, J. L., Mario, C. D., Redwood, S. R., Patterson, T., Pennell, D. J., Rogers, P., et al. (2017) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.27136 · Cited by 2
Kulek, A. R., Undyala, V. V. R., Anzell, A. R., Raghunayakula, S., MacMillan-Crow, L. A., Sanderson, T. H., & Przyklenk, K. (2022) · Cells · doi:10.3390/cells11193083 · Cited by 2
Leboube, S., Camboulives, L., Bochaton, T., Amaz, C., Bergerot, C., Altman, M., Loppinet, T., Cherpaz, M., Monsec, T., Sportouch, C., et al. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1290375 · Cited by 2
Self-citationBerkowitz, D. E., Steenbergen, C., & O'Rourke, B. P. (2016) · Anesthesiology · doi:10.1097/aln.0000000000001114 · Cited by 2
Role of Oxidative Stress in Myocardial Ischemia and Infarction
Jugdutt, B. I., & Jugdutt, B. A. (2019) · Springer eBooks · doi:10.1007/978-981-13-8273-4_14 · Cited by 2
Coronary Heart Disease and Myocardial Ischemia
Groh, S., Dhein, S., & Salameh, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00081-5 · Cited by 2
Arab, O. A., Ly, A., Amrouche, I., Andrei, S., & Mongardon, N. (2019) · Anaesthesia Critical Care & Pain Medicine · doi:10.1016/j.accpm.2019.06.003 · Cited by 2
Grandfather’s moonlighting: hydralazine’s novel liaison with mitochondria
Dudek, J., & Maack, C. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab159 · Cited by 2
Broch, K., Anstensrud, A. K., Woxholt, S., Andersen, G. Ø., & Gullestad, L. L. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.06.005 · Cited by 2
Pré-Condicionamento na Lesão por Isquemia-Reperfusão
Gatto, M., Mota, G. A. F., Pagan, L. U., Gomes, M. J., & Okoshi, M. P. (2021) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20210908 · Cited by 2
Smooth Estimation and Inference with Interval Censored Data
van der Laan, M. J., & Peterson, D. R. (1997) · Collection of Biostatistics Research Archive · Cited by 2
Mohammed, Z. A., Patni, M. A., Qassim, M. M., Naji, N. M., Abid, I. K. A., Kharoufeh, A., Agha, A. A., & Aloti, R. A. (2025) · Cureus · doi:10.7759/cureus.98370 · Cited by 1
Grigoriou, K., Karakasis, P., Lamprou, V., Michas, G., Pamporis, K., Trikas, A. G., Pantos, C. I., & Mourouzis, I. S. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1696749 · Cited by 1
Ichaï, C., Fontaine, E. M., Baumstarck, K., Rimmele, T. R., Strecker, G., Boucékine, M., SZABO, V., Gosset, C., Heng, A.-E., Kerforne, T., et al. (2026) · Intensive Care Medicine · doi:10.1007/s00134-025-08265-6 · Cited by 1
Li, Y., Chen, H., Abudouwayiti, A., Tang, B., Jiang, Z., Pan, Y., Wen, Z., Tuerhongjiang, G., Gao, W., Guo, X., et al. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.152220 · Cited by 1
Local to Systemic Inflammation—From Generation to Prognosis in Acute Coronary Syndrome
Melnic, M., Păduraru, L. F., Lorent, I.-A., Potcoava, A.-M., & Balanescu, S. M. (2026) · Biomedicines · doi:10.3390/biomedicines14040785 · Cited by 1
Tan, D., Lye, Y. E., Patel, P., Minn, N. A., Le, A. C., Bobik, A., & Kyaw, T. S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27104409 · Cited by 1
European Society of Cardiology (ESC) Congress Report From London 2015
Nishiguchi, T., & Akasaka, T. (2015) · Circulation Journal · doi:10.1253/circj.cj-15-1049 · Cited by 1
Breaking Female Hearts: The Gender Gap in Cardiovascular Research
Fiedler, L. R. (2016) · Heart Research - Open Journal · doi:10.17140/hroj-3-e006 · Cited by 1
Pharmacological Agents in the Clinic: Trial and Error
Fiedler, L. R. (2015) · Heart Research - Open Journal · doi:10.17140/hroj-2-122 · Cited by 1
Seto, A. H., Safirstein, J. G., Anwaruddin, S., Dehghani, P., Shah, B., & Tremmel, J. A. (2016) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.26474 · Cited by 1
Sabry, A.-S. M., Elrabat, K. E.-E., Attia, A., & El-Fatah, H. A. (2020) · Benha Medical Journal · doi:10.21608/bmfj.2020.112400 · Cited by 1
Nanomaterials aimed toward the cardiac mitochondria: from therapeutics to nanosafety
Hernández-Fontes, P., Lozano, O., & García‐Rivas, G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85666-9.00002-4 · Cited by 1
High-impact opportunities to address ischemia: a focus on heart and circulatory research
Rimon, R. A., Nelson, V. L., Brunt, K. R., & Kassiri, Z. (2022) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00402.2022 · Cited by 1
Serum Glucocorticoid-Regulated Kinase-1 in Ischemia-Reperfusion Injury: Blessing or Curse
Mozaffari, M. S. (2023) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.123.001846 · Cited by 1
Adel, S. M. H., Kardooni, A., Assareh, A., & Taghizadeh, M. M. (2023) · Armaghane Danesh · doi:10.61186/armaghanj.28.5.8 · Cited by 1
Tripathi, S., Rani, K., Raj, V. S., & Ambasta, R. K. (2024) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2024.02.001 · Cited by 1
Chen, G., Westra, J. S., Yang, X., Zhang, Y., Luo, D., Hu, X., Li, G., Zhou, Y., Tu, S., & Dong, H. (2024) · International Journal of Cardiology · doi:10.1016/j.ijcard.2024.132199 · Cited by 1
Remote Ischemic Conditioning as a Form of Hormesis
Kloner, R. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814253-0.00004-8 · Cited by 1
Metadata
- Authors
- Cung, T.-T., Morel, O., Cayla, G., Rioufol, G., Garcia-Dorado, D., Angoulvant, D., Bonnefoy-Cudraz, E., Guérin, P., Elbaz, M., Delarche, N., Coste, P., Vanzetto, G., Metge, M., Aupetit, J.-F., Jouve, B., Motreff, P., Tron, C., Labeque, J.-N., Steg, P. G., Cottin, Y., Range, G., Clerc, J., Claeys, M. J., Coussement, P., Prunier, F., Moulin, F., Roth, O., Belle, L., Dubois, P., Barragan, P., Gilard, M., Piot, C., Colin, P., De Poli, F., Morice, M.-C., Ider, O., Dubois-Randé, J.-L., Unterseeh, T., Le Breton, H., Béard, T., Blanchard, D., Grollier, G., Malquarti, V., Staat, P., Sudre, A., Elmer, E., Hansson, M. J., Bergerot, C., Boussaha, I., Jossan, C., Derumeaux, G., Mewton, N., & Ovize, M.
- Affiliations
- Centre Hospitalier Universitaire de Nantes (FR)
- Hôpitaux Universitaires de Strasbourg (FR)
- Centre Hospitalier Universitaire de Nîmes (FR)
- Lyon 1 Université (FR)
- Centre Hospitalier De Pau (FR)
- Centre Hospitalier Universitaire de Bordeaux (FR)
- Centre Hospitalier Saint-Joseph Saint-Luc (FR)
- Centre Hospitalier Intercommunal Aix-Pertuis (FR)
- Centre Hospitalier Universitaire de Clermont-Ferrand (FR)
- Hôpital Charles-Nicolle (FR)
- CHU Dijon Bourgogne (FR)
- Antwerp University Hospital (BE)
- AZ Sint-Jan (BE)
- Centre Hospitalier Universitaire d'Angers (FR)
- Centre Hospitalier Régional et Universitaire de Nancy (FR)
- Centre Hospitalier de Mulhouse (FR)
- HUmani - CHU Charleroi-Chimay (BE)
- Clinique du Millénaire (FR)
- Hôpital Privé Jacques Cartier (FR)
- Centre Hospitalier Universitaire de Caen Normandie (FR)
- Lille’s Cardiology Hospital (FR)
- Lund University (SE)
- ORCID
- Morel, Olivier
- Cayla, Guillaume
- Rioufol, Gilles
- Angoulvant, Denis
- Guérin, Patrice
- Delarche, Nicolas
- Coste, Pierre
- Motreff, Pascal
- Tron, Christophe
- Cottin, Yves
- Claeys, Marc J.
- Prunier, Fabrice
- Barragan, Paul
- Gilard, Martine
- Piot, Christophe
- Unterseeh, Thierry
- Sudre, Arnaud
- Hansson, Magnus J.
- Bergerot, Cyrille
- Jossan, Claire
- Mewton, Nathan
- Ovize, Michel
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-09-10
- Volume
- 373
- Issue
- 11
- Pages
- 1021-1031
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2200357463
- Cited by
- 713
- References
- 34
- Citations by year
- 2026: 38 · 2025: 46 · 2024: 48 · 2023: 55 · 2022: 62 · 2021: 57 · 2020: 75 · 2019: 79 · 2018: 70 · 2017: 70 · 2016: 92 · 2015: 20
- FWCI
- 66.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- HAL (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- Lunds Universitet
- Assistance publique-Hôpitaux de Paris
- Universitair Ziekenhuis Antwerpen
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- cyclosporine, ST-elevation myocardial infarction, percutaneous coronary intervention, left ventricular remodeling, ischemia-reperfusion injury, myocardial infarct size, heart failure, intravenous cyclosporine, primary percutaneous coronary intervention, drug safety
- MeSH terms
- Peptidyl-Prolyl Isomerase D, Aged, Combined Modality Therapy, Double-Blind Method, Electrocardiography, Enzyme Inhibitors, Female, Heart Failure, Humans, Injections, Intravenous, Male, Middle Aged, Mortality, Myocardial Infarction, Cyclosporine, Ventricular Remodeling, Cyclophilins, Kaplan-Meier Estimate, Percutaneous Coronary Intervention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
